-transparent.png){kind=logo}
In order to study gastrointestinal irritation caused by the intake of Benoxaprofen, blood loss in stools before and after intake of the drug was measured by labelling red blood cells with 51Cr. The results were compared with previous studies in which the same method was used to determine fecal blood loss after intake of other non-steroidal anti-inflammatory drugs. Anti-inflammatory drugs inhibiting prostaglandin synthetase caused abnormal fecal blood loss in 20 to 60% of the patients. Benoxaprofen which is a weak prostaglandin synthetase inhibitor and acts on the leukotrienes, entailed no abnormal fecal blood loss. It was concluded that with respect to microbleeding, Benoxaprofen had no harmful effect on the gastrointestinal tract in this population.
H Mielants, and
E M Veys, and
K Schelstraete
November 1981,
Die Medizinische Welt,
H Mielants, and
E M Veys, and
K Schelstraete
January 1982,
British medical journal (Clinical research ed.),
H Mielants, and
E M Veys, and
K Schelstraete
February 1982,
British medical journal (Clinical research ed.),
H Mielants, and
E M Veys, and
K Schelstraete
June 1978,
Clinical pharmacology and therapeutics,
H Mielants, and
E M Veys, and
K Schelstraete
October 1986,
The British journal of dermatology,
H Mielants, and
E M Veys, and
K Schelstraete
November 1977,
Lakartidningen,
H Mielants, and
E M Veys, and
K Schelstraete
September 1972,
Current therapeutic research, clinical and experimental,
H Mielants, and
E M Veys, and
K Schelstraete
December 1984,
Annals of internal medicine,
H Mielants, and
E M Veys, and
K Schelstraete
May 1963,
Gastroenterology,
